BlackRock
LUNG icon

BlackRock’s Pulmonx LUNG Stock Holding History

BlackRock’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.43M Sell
2,661,607
-44,583
-2% -$73.7K ﹤0.01% 3973
2025
Q4 		$5.98M Buy
2,706,190
+31,369
+1% +$59K ﹤0.01% 3761
2025
Q3 		$4.33M Sell
2,674,821
-15,977
-0.6% -$33.4K ﹤0.01% 3839
2025
Q2 		$6.97M Sell
2,690,798
-96,598
-3% -$381K ﹤0.01% 3598
2025
Q1 		$18.8M Sell
2,787,396
-62,758
-2% -$444K ﹤0.01% 2982
2024
Q4 		$19.4M Buy
2,850,154
+54,593
+2% +$359K ﹤0.01% 3072
2024
Q3 		$23.2M Buy
2,795,561
+127,795
+5% +$925K ﹤0.01% 2939
2024
Q2 		$16.9M Sell
2,667,766
-369,500
-12% -$2.84M ﹤0.01% 3078
2024
Q1 		$28.2M Sell
3,037,266
-79,797
-3% -$936K ﹤0.01% 2794
2023
Q4 		$39.7M Buy
3,117,063
+181,403
+6% +$1.89M ﹤0.01% 2623
2023
Q3 		$30.3M Buy
2,935,660
+23,894
+0.8% +$277K ﹤0.01% 2700
2023
Q2 		$38.2M Buy
2,911,766
+205,821
+8% +$2.52M ﹤0.01% 2653
2023
Q1 		$30.3M Buy
2,705,945
+12,305
+0.5% +$121K ﹤0.01% 2753
2022
Q4 		$22.7M Buy
2,693,640
+225,355
+9% +$2.14M ﹤0.01% 2962
2022
Q3 		$41.1M Buy
2,468,285
+37,968
+2% +$699K ﹤0.01% 2592
2022
Q2 		$35.8M Sell
2,430,317
-329,738
-12% -$6.79M ﹤0.01% 2721
2022
Q1 		$68.5M Buy
2,760,055
+41,724
+2% +$1.08M ﹤0.01% 2380
2021
Q4 		$87.2M Sell
2,718,331
-19,488
-0.7% -$712K ﹤0.01% 2296
2021
Q3 		$98.5M Buy
2,737,819
+414,180
+18% +$16.3M ﹤0.01% 2227
2021
Q2 		$103M Buy
2,323,639
+1,406,718
+153% +$61.3M ﹤0.01% 2229
2021
Q1 		$41.9M Buy
916,921
+66,313
+8% +$3.8M ﹤0.01% 2734
2020
Q4 		$58.7M Buy
+850,608
New +$41.7M ﹤0.01% 2379

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BlackRock's LUNG Position: Q1 2026 in Review

BlackRock reduced its Pulmonx (LUNG) stake by 1.6% in Q1 2026, selling an estimated $73.7K and leaving 2,661,607 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #3973.

BlackRock first reported a position in LUNG in Q4 2020 and has held it in 22 quarters since. The position peaked at $103M in Q2 2021. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • BlackRock held 2,661,607 shares of Pulmonx worth $3.43M as of Q1 2026.
  • BlackRock sold 44,583 Pulmonx shares in Q1 2026, an estimated $73.7K.
  • Pulmonx made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3973 holding.
  • BlackRock first reported a position in Pulmonx in Q4 2020 and has held it in 22 quarters since.
  • BlackRock's Pulmonx position peaked at $103M in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.